A detailed history of ETF Managers Group, LLC transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, ETF Managers Group, LLC holds 42,442 shares of ATOS stock, worth $32,680. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,442
Previous 31,569 34.44%
Holding current value
$32,680
Previous $16,000 87.5%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

BUY
$0.59 - $0.91 $6,415 - $9,894
10,873 Added 34.44%
42,442 $30,000
Q4 2022

Mar 23, 2023

SELL
$0.5 - $1.01 $2,898 - $5,854
-5,797 Reduced 15.51%
31,569 $16,000
Q3 2022

Nov 14, 2022

SELL
$0.82 - $1.14 $2,163 - $3,008
-2,639 Reduced 6.6%
37,366 $31,000
Q2 2022

Aug 15, 2022

BUY
$0.85 - $1.28 $1,356 - $2,042
1,596 Added 4.16%
40,005 $46,000
Q1 2022

May 13, 2022

SELL
$1.11 - $1.74 $47 - $74
-43 Reduced 0.11%
38,409 $51,000
Q4 2021

Feb 14, 2022

BUY
$1.6 - $3.27 $61,523 - $125,738
38,452 New
38,452 $64,000

Others Institutions Holding ATOS

About ATOSSA THERAPEUTICS, INC.


  • Ticker ATOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,624,000
  • Market Cap $97.5M
  • Description
  • Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...
More about ATOS
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.